Sydvestjysk Sygehus

At Sydvestjysk Sygehus in Esbjerg, a large share of the research focuses on cardiovascular diseases and related nutritional and metabolic disorders. Studies are examining conditions such as atherosclerotic cardiovascular disease, acute myocardial infarction, atrial fibrillation, heart failure, and obesity, with the goal of improving prevention and reducing major cardiovascular events.

• Testing new approaches to lower cardiovascular risk and prevent heart attacks, stroke, and related complications
• Evaluating treatments for atrial fibrillation and safer ways to prevent stroke or systemic embolism
• Studying therapies for heart failure, hypertriglyceridemia, and elevated lipoprotein(a)

These trials combine treatment evaluation with prevention-focused research, reflecting a strong clinical interest in long-term heart and metabolic health.

The site also has active studies in renal medicine, especially chronic kidney disease, end-stage renal disease, and kidney complications linked to type 1 diabetes. This work aims to better understand disease progression and assess whether new treatments can protect kidney function and reduce cardiovascular risk.

• Investigating therapies for chronic kidney disease and diabetic kidney complications
• Exploring ways to slow kidney damage and preserve remaining kidney function
• Assessing whether treatment can also lower broader risks such as heart failure and cardiovascular death

These studies support a more integrated approach to kidney and heart care, which is especially important for patients with long-term metabolic disease.

Clinical research at Sydvestjysk Sygehus includes respiratory tract diseases, otorhinolaryngologic conditions, and supportive care around surgery. Trials are focused on chronic obstructive pulmonary disease, chronic rhinosinusitis with nasal polyposis, and pain management in patients with obstructive sleep apnoea.

• Comparing treatment options for COPD to improve symptom control and reduce exacerbations
• Studying biologic therapies for chronic rhinosinusitis with nasal polyposis to improve daily symptoms and related health problems
• Evaluating perioperative pain treatment to make surgery safer and more comfortable for patients with obesity and sleep-related breathing problems

This area of research combines symptom relief, treatment effectiveness, and safer care for patients with complex respiratory and surgical needs.

The research portfolio also includes studies in nervous system diseases and chronic inflammatory conditions. Current work addresses multiple sclerosis and polymyalgia rheumatica, aiming to improve long-term disease control and reduce relapse or symptom burden.

• Assessing new treatments for multiple sclerosis with a focus on safety and sustained disease control
• Testing whether therapy can help patients with polymyalgia rheumatica maintain remission after relapse
• Supporting research on immune-related inflammation that affects mobility, pain, and quality of life

These studies reflect a broader interest in immune-driven disease and in finding better ways to manage chronic symptoms over time.

The department contributes to trials in hemic and lymphatic diseases and neoplasms, including diffuse large B-cell lymphoma and chronic lymphocytic leukemia. The research is centered on comparing treatment strategies and improving outcomes for patients with blood cancers.

• Evaluating new treatment combinations for lymphoma and leukemia
• Comparing standard and alternative approaches to improve disease control
• Studying options that may offer better effectiveness or tolerability for patients with hematologic cancer

These trials add an important oncology dimension to the site’s research activity, with a clear focus on better disease management and patient benefit.

Another part of the clinical trial activity at the site involves urgent and high-acuity care, including hypotension, shock, and in-hospital cardiac arrest. Research in this area is aimed at improving immediate treatment decisions and outcomes in emergency settings.

• Testing whether early treatment can improve control of shock in the emergency department
• Evaluating therapies used during cardiac arrest to support return of circulation
• Exploring better ways to manage unstable patients when rapid clinical decisions are needed

These studies show a practical focus on life-saving care, where even small improvements in response time and treatment choice can matter greatly.